Article Text

other Versions

PDF
Aggressive combination therapy with intraarticular glucocorticoid injections and conventional DMARDs in early rheumatoid arthritis Two Year Clinical and Radiographic Results From The CIMESTRA Study
  1. Merete Lund Hetland (merete.hetland{at}dadlnet.dk)
  1. Copenhagen University Hospital at Hvidovre, Denmark
    1. Kristian Stengaard-Pedersen (stengaard{at}rheum.dk)
    1. Århus University Hospital, Denmark
      1. Peter Junker (peter.junker{at}ouh.fyns-amt.dk)
      1. Odense University Hospital, Denmark
        1. Tine Lottenburger (tine.lottenburger{at}get2net.dk)
        1. Rheumatism Hospital, University of Southern Denmark, Gråsten, Denmark
          1. Ib Hansen (ibhansen{at}dadlnet.dk)
          1. Århus University Hospital, Denmark
            1. Lis Smedegaard Andersen (lsandersen{at}dadlnet.dk)
            1. Rheumatism Hospital, University of Southern Denmark, Gråsten, Denmark
              1. Ulrik Tarp (utarp{at}as.aaa.dk)
              1. Århus University Hospital, Denmark
                1. Anders Svendsen (asvendsen{at}health.sdu.dk)
                1. Rheumatism Hospital, Univerisity of Southern Denmark, Gråsten, Denmark
                  1. Jens K Pedersen (jensk{at}dadlnet.dk)
                  1. Rheumatism Hospital, Univerisity of Southern Denmark, Gråsten, Denmark
                    1. Henrik Skjødt (hskj{at}dadlnet.dk)
                    1. Copenhagen University Hospital at Hvidovre, Denmark
                      1. Ulrik B Lauridsen (ulrik.birk.lauridsen{at}hvh.regionh.dk)
                      1. Copenhagen Univerisity Hospital at Hvidovre, Denmark
                        1. Torkell Ellingsen (torkell{at}dadlnet.dk)
                        1. Århus University Hospital, Denmark
                          1. Gert van Overeem Hansen (gvoh{at}mail.dk)
                          1. Rheumatism Hospital, University of Southern Denmark, Gråsten, Denmark
                            1. Hanne Lindegaard (lindegaard{at}dadlnet.dk)
                            1. Odense University Hospital, Denmark
                              1. Aage Vestergaard (aage.vestergaard{at}hvh.regionh.dk)
                              1. Copenhagen University Hospital at Hvidovre, Denmark
                                1. Anne Grethe Jurik (jurik{at}dadlnet.dk)
                                1. Århus University Hospital, Denmark
                                  1. Mikkel Østergaard (mo{at}dadlnet.dk)
                                  1. Copenhagen University Hospital at Hvidovre, Denmark
                                    1. Kim Hørslev-Petersen (horslev{at}dadlnet.dk)
                                    1. Rheumatism Hospital, University of Southern Denmark, Gråsten, Denmark

                                      Abstract

                                      Objective: To investigate whether clinical and radiographic disease control can be achieved and maintained in patients with early, active rheumatoid arthritis (RA) during the 2nd year of aggressive treatment with conventional DMARD and intraarticular corticosteroid. This paper presents the results of the 2nd year of the randomized, controlled double-blind CIMESTRA study.

                                      Methods: 160 patients with early RA (<6 months' duration) were randomized to receive intraarticular betamethasone in any swollen joint in combination with step-up treatment with either methotrexate and placebo-cyclosporine (monotherapy) or methotrexate plus cyclosporine (combination therapy) during the first 76 weeks. At week 68 hydroxychlorochine 200 mg daily was added. From week 76-104 cyclosporine/placebo-cyclosporine was tapered to zero.

                                      Results: ACR20, ACR50 and ACR70 were achieved in 88%, 79% and 59% of patients in the combination vs. 72%, 62% and 54% in the monotherapy group (p= 0.03, 0.02 and 0.6 between groups). Patient’s global declined from 50 to 12 vs. 52 to 9, 51% and 50% were in DAS-remission, respectively. Mean±SD progressions in total Sharp/vdHeijde score were 1.42±3.52 and 2.03±5.86 in combination and monotherapy groups, respectively (NS). Serum creatinine levels increased by 7% in the combination group (4% in monotherapy), but hypertension was not more prevalent.

                                      Conclusion: Continuous methotrexate and intraarticular corticosteroid treatment resulted in excellent clinical reponse and disease control at 2 years, and the radiographic erosive progression was minimal. Addition of cyclosporine during the first 76 weeks resulted in significantly better ACR20 and ACR50 responses, but did not have any additional effect on remission rate and radiographic outcome.

                                      • betamethasone
                                      • methotrexate
                                      • placebo-controlled trial
                                      • rheumatoid arthritis

                                      Statistics from Altmetric.com

                                      Request permissions

                                      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.